Publications by authors named "Anna Maria Scattolin"

Claim this Profile
R
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation.
Fabio Guolo, Luana Fianchi, Maria Paola Martelli, Federico Lussana, Francesco Grimaldi, Anna Maria Scattolin

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gilteritinib in FLT3-mutated acute myeloid leukemia: A real-world Italian experience.
Roberto Cairoli, Lorenzo Del Castello, Silvia Imbergamo, Elisabetta Pierdomenico, Cristina Papayannidis, Anna Maria Scattolin

Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial.
Renato Bassan, Sabina Chiaretti, Irene Della Starza, Orietta Spinelli, Alessandra Santoro, Anna Maria Scattolin

Blood Adv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Michelina Dargenio, Massimiliano Bonifacio, Sabina Chiaretti, Antonella Vitale, Nicola Stefano Fracchiolla, Anna Maria Scattolin

Br J Haematol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV.
Patrizia Zappasodi, Chiara Cattaneo, Virginia Valeria Ferretti, Roberto Mina, Andrés José María Ferreri, Anna Maria Scattolin

Hematol Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report.
Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, Fabio Giglio, Mario Annunziata, Anna Maria Scattolin

Haematologica· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study.
Marco Cerrano, Massimiliano Bonifacio, Matteo Olivi, Antonio Curti, Michele Malagola, Anna Maria Scattolin

Haematologica· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Chiara Caprioli, Federico Lussana, Silvia Salmoiraghi, Roberta Cavagna, Ksenija Buklijas, Anna Maria Scattolin

Haematologica· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18-65 years: NILG ALL 10/07.
Renato Bassan, Chiara Pavoni, Tamara Intermesoli, Orietta Spinelli, Manuela Tosi, Anna Maria Scattolin

Blood Cancer J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michele Cavo, Anna Maria Scattolin

Lancet Haematol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program.
Fabio Guolo, Luana Fianchi, Paola Minetto, Marino Clavio, Michele Gottardi, Anna Maria Scattolin

Blood Cancer J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial.
Giacomo Gianfaldoni, Francesco Mannelli, Tamara Intermesoli, Sara Bencini, Damiano Giupponi, Anna Maria Scattolin

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol.
Renato Bassan, Monica Fumagalli, Sabina Chiaretti, Ernesta Audisio, Nicola Cascavilla, Anna Maria Scattolin

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome.
Federico Lussana, Tamara Intermesoli, Francesca Gianni, Cristina Boschini, Arianna Masciulli, Anna Maria Scattolin

Biol Blood Marrow Transplant· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy approaches to treat adult acute lymphoblastic leukemia.
Elena Maino, Massimiliano Bonifacio, Anna Maria Scattolin, Renato Bassan

Expert Rev Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemia.
Renato Bassan, Arianna Masciulli, Tamara Intermesoli, Ernesta Audisio, Giuseppe Rossi, Anna Maria Scattolin

Haematologica· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.
Elena Maino, Anna Maria Scattolin, Piera Viero, Rosaria Sancetta, Anna Pascarella

Mediterr J Hematol Infect Dis· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia.
Orietta Spinelli, Manuela Tosi, Barbara Peruta, Marie Lorena Guinea Montalvo, Elena Maino, Anna Maria Scattolin

Mediterr J Hematol Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future management of Ph/BCR-ABL positive ALL.
Elena Maino, Rosaria Sancetta, Piera Viero, Silvia Imbergamo, Anna Maria Scattolin

Expert Rev Anticancer Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program.
Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi, Federica Delaini, Claudio Romani, Anna Maria Scattolin

Haematologica· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Renato Bassan, Orietta Spinelli, Elena Oldani, Tamara Intermesoli, Manuela Tosi, Anna Maria Scattolin

Blood· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis